Skip to main content
Clinical Trials/ACTRN12607000345482
ACTRN12607000345482
Completed
Phase 4

The potential of selenium supplements provided as selenium-enriched dairy protein or yeast selenium to improve selenium status

Professor Graeme Young MD, FRACP0 sites20 target enrollmentJune 26, 2007

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Plasma selenium concentration Levels of biomarkers in rectal epithelium
Sponsor
Professor Graeme Young MD, FRACP
Enrollment
20
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 26, 2007
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Professor Graeme Young MD, FRACP

Eligibility Criteria

Inclusion Criteria

  • Healthy, with no active bowel disease, orWith a previous history of adenoma removal \>6 months ago, With plasma selenium at or below 100 µg/dL. (to ensure that people with a High background selenium status are not included in the study),

Exclusion Criteria

  • Any allergy or intolerance to milk/dairy productsPlasma Se above the 95th percentile of the current population (i.e. \>100µg/dL)Evidence of any active mucosal bowel disease, eg colitis, or of malabsorption.With no evidence of any other active clinical disease precluding participation in the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials